the Company’s internally developed GeminiOne® Transcatheter Edge-to-EdgeRepair (“TEER”) System (“GeminiOne®”) has recently received approval from theNational Medical Products Administration of the People’s Republic of China (國家藥品監督管理局) (the “NMPA”) for its registration application.